Brief: Nordic Nanovector Publishes Data From Phase 2 Clinical Trials With Betalutin On European Clinical Trials Database
18/04/2023 11:53
April 18 (Reuters) - Nordic Nanovector ASA NANOVN.OL :
* NORDIC NANOVECTOR PUBLISHES DATA FROM THE PARADIGME PHASE
2
CLINICAL TRIALS WITH BETALUTIN® ON EUROPEAN CLINICAL TRIALS
DATABASE
Source text for Eikon: ID:nPrerd2sPa
Further company coverage: NANOVN.OL
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Thor Medical ASA
See all newsBrief: Thor Medical Enters Partnership Agreement With Minerva Imaging
Brief: Thor Medical Partners With Eckert & Ziegler
Brief: Thor Medical Completes Alphaone Production Facility At Herøya Industrial Park
Brief: Thor Medical Enters Multiyear Agreement With Node Pharma
Brief: Thor Medical H2 EBITDA Loss NOK 25.7 Mln